Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
Launched by PAPWORTH HOSPITAL NHS FOUNDATION TRUST · Aug 27, 2019
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or older
- • Able to give informed consent
- Exclusion Criteria:
- • Patient with known sleep disordered breathing using a treatment device (e.g. continuous positive airway pressure) on the night of the study.
- • Polysomnography study records less than 4 hours of respiratory data
About Papworth Hospital Nhs Foundation Trust
Papworth Hospital NHS Foundation Trust is a leading healthcare institution in the United Kingdom, renowned for its specialized services in cardiothoracic medicine and surgery. As a prominent clinical trial sponsor, the Trust is dedicated to advancing medical research and improving patient outcomes through innovative trials and studies. With a commitment to excellence in patient care, Papworth Hospital collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to facilitate cutting-edge research that addresses critical health challenges. The Trust's experienced team of clinicians and researchers is focused on delivering high-quality evidence that contributes to the advancement of healthcare practices and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, Cambridgeshire, United Kingdom
Patients applied
Trial Officials
Ian Smith, MD
Principal Investigator
Royal Papworth Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials